The desirable properties of a matrix for tissue engineering applications appears to shift from a minimal model of supporting cell growth to a more inclusive role as a matrix to trigger the regeneration process. This requirement has propelled efforts towards bio-functionalization of matrices both by chemical and textural modification of most advanced materials, including silk. Amongst different biomaterials, silk fibroin (SF) has been extensively used for various tissue engineering applications, because of its low immunogenicity and good mechanical strength, although low biological activity and a poor biodegradability rate has remained its major limitation for use in regenerative medicine. In the present study, the physical as well as biological properties of SF have been improved by incorporation of honey, a natural healing agent. Honey-blended SF films (HSF) demonstrated increased mechanical strength together with enhanced wettability, swelling ability and degradability without hampering the original mechanical and biological properties of both honey and SF. In addition, parallel-aligned nanostructures were produced over native SF and HSF using soft lithography to form two-dimensional nano-patterned membranes. HSF films demonstrated enhanced surface roughness in flat membranes and even more so in nano-patterned membranes when compared with native SF membranes which are essential for cellular adhesion and proliferation. Furthermore, biocompatibility and cellular behavior such as adhesion, proliferation, spreading and interaction of 3T3 fibroblast cells were improved using HSF when compared with using native SF membranes. Thus, HSF membranes with enhanced bio-physical properties are a potential material for use in regenerative medicine and tissue engineering applications.
2 August 2016 in ACS Biomaterials Science & Engineering
Flaviviruses can lead to severe neurotropic‐encephalitic pathology, for which the viral nonstructural protein 1 (NS1) plays a major role. 2D in vitro cellular systems and animal models are currently used to investigate the effects of flavivirus NS1 in the brain‐blood barrier do not fully capture pathogenesis and drug responses seen in humans. Here is reported the development of a perfusable human brain microvascular network‐on‐a‐chip (BMVasChip) model which incorporates brain endothelial cells and pericytes and recapitulates the cellular organization and expression of brain blood barrier‐specific markers, including intracellular junction proteins. This BMVasChip model is used to investigate vasculopathy caused by exposure to a panel of flavivirus NS1 proteins, including Japanese encephalitis (JEV), West Nile (WNV), and dengue virus (DENV) NS1 proteins. The BMVasChip platform is able to demonstrate flavivirus NS1‐induced pathophysiological phenotypes in the BMVasChip, including early and late endothelial activation and dysfunction features such as loss of barrier integrity, morphological features, and production of pro‐inflammatory markers in a virus, dose, and time‐dependent manner. In summary, the BMVasChip model recapitulates key features of endothelial dysfunction, potentially reflecting NS1's role in viral pathogenesis and providing targets for antiviral therapeutics and vaccine development.